(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

EPLEX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

EPLEX

ST13

US500000086658228

Class

1, 5, 9, 10

Filing

86658228

Registration

5266472

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

52

Latest update

08/15/2026

Trademark type

Combined

Nice classes

1, 5, 9, 10

Filing date

06/10/2015

Registration date

08/15/2017

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/09/2023

Last transaction

08/15/2026

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

10/23/2015

First use in commerce

03/18/2016

Drawing code

3

Owner type

16

Owner location

MANNHEIM, DE

Examiner

SANTOMARTINO, MARTHA L

Law office

M30

Current location

TMO LAW OFFICE 112

Mark description

The mark consists of the stylized term "EPLEX" where the lower case letter "e" is set off against a shaded blue circle, the term "PLEX" is in the color dark gray, and the upper right half of the letter "X" is a faded blue. The color white represents background, outlining, shading and/or transparent areas and is not part of the mark.

Holders and representatives

Holders

ROCHE DIAGNOSTICS GMBH
GenMark Diagnostics, Inc.

Representatives

Mona Gupta Roche Diagnostics Operations, Inc.

Technical classification

Nice Classes

Class 1Class 5Class 9Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Reagentskits and cartridges comprised primarily of reagentsbeadsoligonucleotide probes and primers for scientific and research use in connection with the isolationpurificationamplificationanalysislabeling and detection of nucleic acids

Class 5

Reagentskits and cartridges comprised primarily of reagentsbeadsoligonucleotide probes and primers for medicalclinicalmedical laboratory or medical diagnostic use in connection with the isolationpurificationamplificationanalysislabeling and detection of nucleic acids

Class 9

Laboratory equipmentdevices for bioanalysis incorporating cartridges for sample preparationnucleic acid purificationnucleic acid amplification and electrochemical detectionsoftware for use therewith

Class 10

Medical equipmentdevices for bioanalysis incorporating cartridges for sample preparationnucleic acid purificationnucleic acid amplification and electrochemical detectionsoftware for use therewith sold as a unit

Publications

History of USPTO decisions and trademark events.

52 publications found

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

08/15/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/10/2024

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

09/10/2024

EWOR

TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED

09/10/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

09/10/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

09/10/2024

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

03/09/2023

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

03/09/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/08/2023

E815

TEAS SECTION 8 & 15 RECEIVED

08/22/2022

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

08/15/2022

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

10/04/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/04/2021

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

10/04/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/04/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/04/2021

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

10/04/2021

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

09/22/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

08/15/2017

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

07/11/2017

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

07/10/2017

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

06/22/2017

SUPC

STATEMENT OF USE PROCESSING COMPLETE

06/21/2017

EX3G

SOU EXTENSION 3 GRANTED

06/21/2017

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

06/07/2017

IUAF

USE AMENDMENT FILED

06/02/2017

EXT3

SOU EXTENSION 3 FILED

06/02/2017

EEXT

SOU TEAS EXTENSION RECEIVED

06/02/2017

EISU

TEAS STATEMENT OF USE RECEIVED

06/02/2017

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

01/11/2017

EX2G

SOU EXTENSION 2 GRANTED

01/09/2017

EXT2

SOU EXTENSION 2 FILED

01/09/2017

EEXT

SOU TEAS EXTENSION RECEIVED

01/09/2017

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

08/13/2016

EX1G

SOU EXTENSION 1 GRANTED

08/11/2016

EXT1

SOU EXTENSION 1 FILED

08/11/2016

EEXT

SOU TEAS EXTENSION RECEIVED

08/11/2016

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

03/08/2016

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/12/2016

PUBO

PUBLISHED FOR OPPOSITION

01/12/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/24/2015

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/28/2015

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/13/2015

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/12/2015

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/12/2015

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/19/2015

GNRT

NON-FINAL ACTION E-MAILED

09/19/2015

CNRT

NON-FINAL ACTION WRITTEN

09/19/2015

DOCK

ASSIGNED TO EXAMINER

09/19/2015

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

06/16/2015

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/15/2015

NWAP

NEW APPLICATION ENTERED

06/13/2015

Continuous trademark protection

Get notified about every new filing that threatens EPLEX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.